Floatz logo

pf-3512676

Ciliary Body and Choroid Melanoma, Small Size

Ahmad TarhiniPhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

64 Active assets in the Ciliary Body and Choroid Melanoma, Small Size cohort.

Asset / SponsorPhaseRating
Ifa
Craig L Slingluff, Jr
Phase 2BBB
Tyrosinase Peptide
University of Southern California
Phase 3BB
Sargramostim
Thomas Jefferson University
Phase 3BB
Cyclophosphamide
Beijing Biotech
Phase 2/3BB
Gm-Csf
Ahmad Tarhini
Phase 2BB

View all 50 →

Same molecule, other indications

pf-3512676 is also rated in:

mantle cell lymphomaDormant
B
Indicative ·
63 / 100
View asset →
non-Hodgkin lymphomaDormant
B
Indicative ·
63 / 100
View asset →
follicular lymphomaDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →